Matias Bustos

24PUBLICATIONS
80CO-AUTHORS
Predictive and prognostic markersAllergyObstetrics and gynaecologyMedical biotechnology diagnostics (incl. biosensors)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 24, 2026
UBQLN4 Is a Prognostic Biomarker in Intrahepatic Cholangiocarcinoma That Is Associated with Cisplatin Resistance.

|Aug 26, 2026
Urine and Blood-Derived MicroRNAs in Patients with Kidney Cancer: A Review of Clinical Utility and Recent Developments.

|Apr 12, 2025
Transcriptomic miRNA and mRNA signatures in primary prostate cancer that are associated with lymph-node invasion.

Matias A Bustos, Kelly K Chong, Yoko Koh

|Oct 18, 2024
Interferon-induced factor 16 is essential in metastatic melanoma to maintain STING levels and the immune responses upon IFN-γ response pathway activation.

Yuta Kobayashi, Matias A Bustos, Yoshinori Hayashi

|Sep 14, 2024
Impact of Cryopreserved Placental Allografts on Biochemical Recurrence in Prostate Cancer.

Josh Gottlieb, Douglas A Hanes, Matias A Bustos

|Aug 20, 2024
Pilot Study of Plasma miRNA Signature Panel for Differentiating Single vs Multiglandular Parathyroid Disease.

Melanie Goldfarb, Matias A Bustos, Jamie Moon

Pageof 4

Frequent Collaborators

8 joint publications

Dave S B Hoon

4 joint publications

Rebecca Gross

2 joint publications

Negin Rahimzadeh

2 joint publications

Chantale Bernatchez